| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director +1 more
20 companies
Perceptive Advisors LLC is a 10% Owner at FOLD with holdings across 20 companies. Recent SEC Form 4 filings include 12 buys and 5 sells.
Estimated insider holdings value: $1175.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | LIANY Lianbio | Director, 10% Owner | Buy | 69,000 | $3.13 | $215,970.00 | +2.6% | - | - | |
| May 25, 2022 | LIANY Lianbio | Director, 10% Owner | Buy | 171,251 | $2.58 | $442,363.97 | +2.3% | - | - | |
| Apr 18, 2022 | CRNX Crinetics Pharmaceuticals, Inc. | 10% Owner | Buy | 157,515 | $22.22 | $3,499,983.30 | +3.1% | -15.4% | -26.5% | |
| Apr 12, 2022 | LYRA Lyra Therapeutics, Inc. | Director, 10% Owner | Buy | 5,924,170 | $4.22 | $24,999,997.40 | +306.3% | -1.8% | -59.5% | |
| Dec 8, 2021 | NAUT Nautilus Biotechnology, Inc. | Director | Buy | 200,000 | $5.36 | $1,072,000.00 | +2.2% | -28.8% | -68.4% | |
| Nov 3, 2021 | LIANY Lianbio | Director, 10% Owner | Buy | 2,270,000 | $15.98 | $36,270,200.00 | +4.2% | - | - | |
| Nov 2, 2021 | LIANY Lianbio | Director, 10% Owner | Buy | 220,000 | $14.59 | $3,210,000.00 | +1.6% | - | - | |
| Oct 25, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | 10% Owner | Buy | 1,200,000 | $19.80 | $23,760,000.00 | +30.3% | -9.7% | -17.3% | |
| Sep 30, 2021 | ADMA Adma Biologics, Inc. | 10% Owner | Sell | 260,603 | $1.15 | $299,235.86 | -0.6% | +15.0% | +115.0% | |
| Sep 27, 2021 | ADMA Adma Biologics, Inc. | 10% Owner | Sell | 500,000 | $1.25 | $622,500.00 | -1.8% | +1.6% | +93.5% |